GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fuji Pharma Co Ltd (TSE:4554) » Definitions » Gross-Profit-to-Asset %

Fuji Pharma Co (TSE:4554) Gross-Profit-to-Asset % : 22.08% (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Fuji Pharma Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Fuji Pharma Co's annualized Gross Profit for the quarter that ended in Mar. 2024 was 円18,724 Mil. Fuji Pharma Co's average Total Assets over the quarter that ended in Mar. 2024 was 円84,795 Mil. Therefore, Fuji Pharma Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 22.08%.


Fuji Pharma Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Fuji Pharma Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fuji Pharma Co Gross-Profit-to-Asset % Chart

Fuji Pharma Co Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27.75 24.24 23.38 20.83 20.53

Fuji Pharma Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.35 18.45 23.51 16.72 22.08

Competitive Comparison of Fuji Pharma Co's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Fuji Pharma Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fuji Pharma Co's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fuji Pharma Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Fuji Pharma Co's Gross-Profit-to-Asset % falls into.



Fuji Pharma Co Gross-Profit-to-Asset % Calculation

Fuji Pharma Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Sep. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Sep. 2023 )/( (Total Assets (A: Sep. 2022 )+Total Assets (A: Sep. 2023 ))/ count )
=16514/( (75538+85332)/ 2 )
=16514/80435
=20.53 %

Fuji Pharma Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=18724/( (84583+85006)/ 2 )
=18724/84794.5
=22.08 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Fuji Pharma Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Fuji Pharma Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Fuji Pharma Co (TSE:4554) Business Description

Traded in Other Exchanges
Address
5-7 Sanban-cho, Chiyoda-ku, Tokyo, JPN, 102-0075
Fuji Pharma Co.,Ltd. is the development, manufacture, and marketing of pharmaceutical products, such as injection agents, internal drugs, drugs for external use, and diagnostic products.

Fuji Pharma Co (TSE:4554) Headlines

No Headlines